Literature DB >> 11390410

Succinic acids as potent inhibitors of plasmid-borne IMP-1 metallo-beta-lactamase.

J H Toney1, G G Hammond, P M Fitzgerald, N Sharma, J M Balkovec, G P Rouen, S H Olson, M L Hammond, M L Greenlee, Y D Gao.   

Abstract

IMP-1 metallo-beta-lactamase (class B) is a plasmid-borne zinc metalloenzyme that efficiently hydrolyzes beta-lactam antibiotics, including carbapenems, rendering them ineffective. Because IMP-1 has been found in several clinically important carbapenem-resistant pathogens, there is a need for inhibitors of this enzyme that could protect broad spectrum antibiotics such as imipenem from hydrolysis and thus extend their utility. We have identified a series of 2,3-(S,S)-disubstituted succinic acids that are potent inhibitors of IMP-1. Determination of high resolution crystal structures and molecular modeling of succinic acid inhibitor complexes with IMP-1 has allowed an understanding of the potency, stereochemistry, and structure-activity relationships of these inhibitors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390410     DOI: 10.1074/jbc.M104742200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Docking and scoring of metallo-beta-lactamases inhibitors.

Authors:  Lars Olsen; Ingrid Pettersson; Lars Hemmingsen; Hans-Werner Adolph; Flemming Steen Jørgensen
Journal:  J Comput Aided Mol Des       Date:  2004-04       Impact factor: 3.686

2.  Mimicking natural evolution in metallo-beta-lactamases through second-shell ligand mutations.

Authors:  Pablo E Tomatis; Rodolfo M Rasia; Lorenzo Segovia; Alejandro J Vila
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

3.  Expression, purification, crystallization and preliminary X-ray analysis of Aeromonas hydrophilia metallo-beta-lactamase.

Authors:  Nandini Sharma; Jeffrey H Toney; Paula M D Fitzgerald
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-01-08

4.  Conformational changes in the metallo-beta-lactamase ImiS during the catalytic reaction: an EPR spectrokinetic study of Co(II)-spin label interactions.

Authors:  Narayan Sharma; Zhenxin Hu; Michael W Crowder; Brian Bennett
Journal:  J Am Chem Soc       Date:  2008-06-04       Impact factor: 15.419

5.  Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.

Authors:  Erin E Gill; Octavio L Franco; Robert E W Hancock
Journal:  Chem Biol Drug Des       Date:  2015-01       Impact factor: 2.817

Review 6.  Fragment-based inhibitor discovery against β-lactamase.

Authors:  Derek A Nichols; Adam R Renslo; Yu Chen
Journal:  Future Med Chem       Date:  2014-03       Impact factor: 3.808

7.  Catalytic role of the metal ion in the metallo-beta-lactamase GOB.

Authors:  María-Natalia Lisa; Lars Hemmingsen; Alejandro J Vila
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

8.  N-arylsulfonyl hydrazones as inhibitors of IMP-1 metallo-beta-lactamase.

Authors:  Stefan Siemann; Darryl P Evanoff; Laura Marrone; Anthony J Clarke; Thammaiah Viswanatha; Gary I Dmitrienko
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

9.  Amidation of bioactive peptides: the structure of the lyase domain of the amidating enzyme.

Authors:  Eduardo E Chufán; Mithu De; Betty A Eipper; Richard E Mains; L Mario Amzel
Journal:  Structure       Date:  2009-07-15       Impact factor: 5.006

10.  Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase.

Authors:  Mariano M González; Magda Kosmopoulou; Maria F Mojica; Valerie Castillo; Philip Hinchliffe; Ilaria Pettinati; Jürgen Brem; Christopher J Schofield; Graciela Mahler; Robert A Bonomo; Leticia I Llarrull; James Spencer; Alejandro J Vila
Journal:  ACS Infect Dis       Date:  2015-07-20       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.